| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1038/NRRHEUM.2010.47 |
| P698 | PubMed publication ID | 20386563 |
| P50 | author | Ricard Cervera i Segura | Q53547424 |
| Gerard Espinosa | Q60326205 | ||
| P2860 | cites work | The management of thrombosis in the antiphospholipid-antibody syndrome | Q72619159 |
| Primary antiphospholipid syndrome: functional outcome after 10 years | Q73324341 | ||
| Catastrophic antiphospholipid syndrome and sepsis. A common link? | Q80261265 | ||
| Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines | Q22255576 | ||
| Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals | Q28210153 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. | Q33342481 | ||
| Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients | Q33369688 | ||
| The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence | Q33382314 | ||
| Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients | Q33502956 | ||
| Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients | Q34435380 | ||
| Thrombotic storm: when thrombosis begets thrombosis | Q34467096 | ||
| Catastrophic antiphospholipid syndrome: lessons from the "CAPS Registry"--a tribute to the late Josep Font | Q36951067 | ||
| A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies | Q37020336 | ||
| Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors | Q37249543 | ||
| Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients | Q43519903 | ||
| The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. | Q51766317 | ||
| Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation: an 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia. | Q52858010 | ||
| The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. | Q53189388 | ||
| Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. | Q53354829 | ||
| Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients | Q56907610 | ||
| The catastrophic antiphospholipid syndrome | Q68136491 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 296-300 | |
| P577 | publication date | 2010-04-13 | |
| P1433 | published in | Nature Reviews Rheumatology | Q2107227 |
| P1476 | title | Antiphospholipid syndrome: frequency, main causes and risk factors of mortality | |
| P478 | volume | 6 |
| Q41966493 | A large and massive abdominal venous thrombosis associated with the presence of a big axillary mass, lupus-like syndrome and antiphospholipid antibodies |
| Q37853593 | An approach to the patient with retiform purpura |
| Q30235423 | Antiphospholipid syndrome |
| Q37228076 | Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study |
| Q57234943 | Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies |
| Q38039441 | Autoimmune diseases and venous thromboembolism: a review of the literature. |
| Q38152823 | Cardiovascular comorbidities in antiphospholipid syndrome |
| Q34003460 | Cardiovascular risk factors in the antiphospholipid syndrome |
| Q41870499 | Catastrophic antiphospholipid syndrome presenting with sudden renal failure: The lesson lies in vascular lesions |
| Q53544250 | Cutaneous manifestations in antiphospholipid syndrome. |
| Q35153652 | HIV-Associated Venous Thromboembolism |
| Q35419865 | Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. |
| Q43931359 | Impaired aerobic exercise capacity and cardiac autonomic control in primary antiphospholipid syndrome |
| Q35711767 | Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus |
| Q37873722 | Intravenous immunoglobulin therapy in rheumatic diseases |
| Q33425472 | Late-Onset Immune Thrombocytopenic Purpura After Withdrawal of Interferon Treatment for Chronic Hepatitis C Infection: A Case Report |
| Q41767987 | M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies |
| Q55010389 | Omega-3 Fatty Acid Supplementation Improves Endothelial Function in Primary Antiphospholipid Syndrome: A Small-Scale Randomized Double-Blind Placebo-Controlled Trial. |
| Q41872246 | Rapidly progressive intracranial artery stenosis in primary antiphospholipid syndrome |
| Q38016378 | Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease |
| Q38153449 | Thromboembolism risk following recurrent miscarriage |
| Q84378951 | [Pulmonary emergencies in connective tissues disorders and vasculitides] |
Search more.